简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-06-24 09:56 Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries
2025-06-24 09:45 Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges
2025-06-23 10:24 NEL Animal Cardiovascular Center Achieves World’s First Surgical Correction of Complex VSD in Canine Patient
2025-06-23 10:00 Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting
2025-06-23 09:51 SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit
2025-06-19 11:13 LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials
2025-06-19 10:07 DNP to Take Controlling-Stake in Laxton
2025-06-18 16:42 SINOVAC Announces New Board Member
2025-06-18 16:15 ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years
2025-06-18 10:53 Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
2025-06-16 17:36 HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation
2025-06-16 10:54 Kao Releases the Kao Integrated Report 2025
2025-06-13 17:42 HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
2025-06-13 15:13 Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies
2025-06-13 14:53 New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
2025-06-13 10:16 Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
2025-06-13 09:14 FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025
2025-06-11 10:18 HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
2025-06-11 09:50 Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer
2025-06-11 09:30 Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research

Business Wire Weibo

Press Releases

Latest Releases